Topo Therapeutics offers expertise in structural biology and accelerates transmembrane protein drug discovery.
Topo Therapeutics has raised $10.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2024.
Topo Therapeutics is headquartered in Cambridge, United States.
Topo Therapeutics offers expertise in structural biology and accelerates transmembrane protein drug discovery.
Topo Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Topo Therapeutics — Funding & Investors." VCBacked, December 31, 2024, https://www.vcbacked.co/company/topo-therapeutics. Accessed August 15, 2026.
VCBacked. (2024). Topo Therapeutics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/topo-therapeutics
{{cite web |title=Topo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/topo-therapeutics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated